Biomarkers and translational research and precision medicine

38P - Defining the physiological miRNA landscape in nipple aspirate fluid

Authors
  • Susana I. Patuleia (Utrecht, Netherlands)
  • Cathy B. Moelans (Utrecht, Netherlands)
  • Carla H. Van Gils (Utrecht, Netherlands)
  • Paul J. Van Diest (Utrecht, Netherlands)
  • Elsken Van der Wall (Utrecht, Netherlands)
Speakers
  • Susana I. Patuleia (Utrecht, Netherlands)

Previous ePoster

No ePoster preview available
36P - Endocrine implications in male breast cancer in Bulgaria

Next ePosters
40P - WNT, Hedgehog and NOTCH signaling pathways in triple negative breast cancer with high and low content of cancer stem cells
42P_PR - Painting the global picture of HER2-testing for breast cancer. The ONCOLLEGE-001 survey study
43P - CIP2A as a novel target to combat basal like breast cancer
46P - BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
49P - The metastatic potential of grade I breast carcinoma of no special type: A deep insight into putative molecular mechanisms
50P - ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy
51P - Higher ER load is not associated with better outcome in stage I-III breast cancer
52P - The early changes of ΔSUV is a predictive marker of response and outcome in everolimus treated patients with mBC
53P - Activity of chemotherapy drugs in patient-derived xenografts (PDXs) from chemotherapy naïve local-regional triple negative breast cancer (LR-TNBC) patients
54P - Prognostic and predictive value of phosphorylated HER2, HER3 and PTEN expression in patients with HER2-positive breast cancer treated with trastuzumab